Reaction
Diplegia reporting signals
As of the last recalculation, Diplegia appears in 1,963 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is AMPICILLIN (PRR 24.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ampicillin | 19 | 24.6 | 24.6 |
| Ampicillin Sodium | 19 | 24.6 | 24.6 |
| Bupivacaine | 17 | 19.5 | 19.5 |
| Gentamicin Sulfate | 17 | 11.5 | 11.5 |
| Erythromycin | 18 | 10.3 | 10.3 |
| Heparin Sodium | 13 | 10.1 | 10.1 |
| Interferon Beta-1B | 18 | 10.0 | 10.0 |
| Cephalexin | 18 | 8.9 | 8.9 |
| Sevoflurane | 6 | 7.7 | 7.7 |
| Cefepime | 10 | 7.4 | 7.4 |
| Cefepime Hydrochloride | 11 | 7.3 | 7.3 |
| Interferon Beta-1A | 123 | 7.1 | 7.1 |
| Ceftriaxone | 21 | 6.8 | 6.9 |
| Zidovudine | 8 | 6.4 | 6.4 |
| Siponimod | 5 | 6.0 | 6.0 |
| Rotigotine | 8 | 5.9 | 5.9 |
| Ofatumumab | 18 | 5.8 | 5.8 |
| Suvorexant | 7 | 5.7 | 5.7 |
| Rasagiline Mesylate | 6 | 5.7 | 5.7 |
| Pitavastatin Calcium | 5 | 5.2 | 5.2 |
| Brentuximab Vedotin | 5 | 5.2 | 5.2 |
| Peginterferon Beta-1A | 6 | 4.9 | 4.9 |
| Dalfampridine | 30 | 4.5 | 4.5 |
| Enzalutamide | 20 | 3.6 | 3.6 |
| Tafamidis | 4 | 3.6 | 3.6 |
| Fingolimod Hcl | 29 | 3.6 | 3.6 |
| Diroximel Fumarate | 4 | 3.6 | 3.6 |
| Dimethyl Fumarate | 40 | 3.5 | 3.5 |
| Glatiramer Acetate | 18 | 3.2 | 3.2 |
| Natalizumab | 52 | 3.1 | 3.1 |